Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VERV | KALV | AMLX | ||
| Company | Verve Therapeutics Inc | Kalvista Pharmaceuticals Inc | Amylyx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.55 | 9.02 | 5.23 | ||
| High | 4.69 | 9.33 | 5.42 | ||
| Low | 4.44 | 8.75 | 4.98 | ||
| Last | 4.60 | 9.32 | 5.19 | ||
| Change | +0.05 | +0.36 | -0.04 | ||
| % Change | +1.10% | +4.07% | -0.76% | ||
| Volume | 1,397,900 | 493,200 | 1,889,100 | ||
| 20-Day Average Volume | 1,654,185 | 418,195 | 1,693,385 | ||
| Previous Close | 4.55 | 8.96 | 5.23 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.71 | 10.63 | 5.63 | ||
| 20-Day Raw Stochastic | 6.75% | 14.02% | 22.96% | ||
| 20-Day Relative Strength | 38.83% | 38.33% | 54.09% | ||
| Weighted Alpha | -61.76 | -14.23 | +114.82 | ||
| Today's Opinion | 72% Sell | 100% Sell | 64% Buy | ||
| Previous Opinion | 72% Sell | 100% Sell | 64% Buy | ||
| Last Month's Opinion | 56% Sell | 56% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.50% since 11/14/24 | -4.85% since 11/14/24 | +3.39% since 11/14/24 | ||
| Low | 4.44 on 11/21/24 | 8.75 on 11/21/24 | 4.57 on 11/15/24 | ||
| High | 5.44 on 11/15/24 | 9.96 on 11/15/24 | 5.88 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -17.12% since 10/21/24 | -24.31% since 10/21/24 | +11.37% since 10/21/24 | ||
| Low | 4.44 on 11/21/24 | 8.75 on 11/21/24 | 4.45 on 10/22/24 | ||
| High | 6.81 on 11/06/24 | 12.85 on 11/04/24 | 7.27 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | -10.16% since 08/21/24 | -25.87% since 08/21/24 | +129.65% since 08/21/24 | ||
| Low | 4.37 on 10/10/24 | 8.75 on 11/21/24 | 2.05 on 08/28/24 | ||
| High | 6.81 on 11/06/24 | 13.52 on 09/03/24 | 7.27 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | -16.97% since 05/21/24 | -19.68% since 05/21/24 | +188.33% since 05/21/24 | ||
| Low | 4.30 on 08/14/24 | 8.75 on 11/21/24 | 1.58 on 06/17/24 | ||
| High | 7.96 on 07/16/24 | 15.50 on 07/24/24 | 7.27 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 385,221 | 387,206 | 358,506 | ||
| Shares Outstanding, K | 84,664 | 43,215 | 68,548 | ||
| Annual Sales | 11,760,000 | 0 | 380,790,000 | ||
| Annual Net Income | -200,070,000 | -126,640,000 | 49,270,000 | ||
| Last Quarter Sales | 6,870,000 | 0 | 420,000 | ||
| Last Quarter Net Income | -50,130,000 | -40,440,000 | -72,700,000 | ||
| 60-Month Beta | 1.75 | 0.92 | -0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 11/05/24 | -0.87 on 09/05/24 | -0.53 on 11/07/24 | ||
| Latest Earnings Date | 11/05/24 | 12/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 03/28/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||